| Name | Title | Contact Details |
|---|
Manitoba Institute of Child Health is a Winnipeg, MB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Conkerexe Biosciences is a Tempe, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CME was founded in 1978 by psychiatrist John Schwartz, whose vision was to provide high-quality, practical continuing medical education and information for mental health clinicians throughout the United States. In its first decade, CME successfully
Croes Communications, Inc is a Oak Hall, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.